Michael Jensen, MD
Dr. Jensen is an internationally recognized leader in the field of CAR T-cell immunotherapy with over 20-years’ experience in the research and clinical translation of this therapeutic modality. He has focused the application of his work to childhood cancers. Dr. Jensen graduated from the University of Pennsylvania School of Medicine and then completed training in Pediatric Hematology and Oncology at the University of Washington(UW)/Fred Hutchinson Cancer Research Center (FHCRC) with a focus on the immunobiology of tumor-specific T-cells. After completing his fellowship at FHCRC, he joined the faculty at California’s City of Hope National Medical Center where he built a translational research program integrating gene therapy and cellular immunotherapy for cancer. Dr. Jensen is the founding Director of the Ben Towne Center for Childhood Cancer at Seattle Children’s Research Institute where he continues to pursue a pipeline of cures that treat childhood cancer with the goal of reducing the long-term, debilitating side effects of traditional treatments. As the founding Executive Director of CureWorks, Dr. Jensen is committed to accelerating the progress of immunotherapies for childhood cancers and expanding the access to these therapies for children around the world.
Janet & Jim Sinegal Endowed Chair and Professor, Division of Pediatric Hematology-Oncology, Department of Pediatrics
University of Washington School of Medicine
Joint Member, Fred Hutchinson Cancer Research Center
Adjunct Professor, Department of Bioengineering,
UW School of Medicine